Composite surge masks QoQ momentum loss; guidance maintained
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Hit composite growth 25-30% guidance (delivered 29.3%). Maintained volume growth >15% and PAT guidance. Missed working capital targets; value-added mix lagging.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Strong Q1 revenue/PAT growth (25%/22% YoY) and composite momentum (29.3%) validate core business health, but QoQ PAT decline (-12.2%), working capital deterioration to 110 days (vs 90-day target), and value-added product mix stuck at 25.4% (vs 35% target) signal operational challenges beneath headline growth. Guidance MAINTAINED (not raised), and management is realistic on polymer price volatility. Suitable as a quality compounder with execution risk.
₹1694 Cr
Revenue · +25.1% YoY₹116 Cr
Reported PAT · +22.2% YoYFlat
Margins · vs guidance: CorroboratedDid the claims hold up?
Composite products delivered 29% growth
METTranscript states 29.3% composite growth in Q1
PAT growth 22.2% reflects operational excellence
OVERSTATEDPAT growth 22.2% YoY supported by EBITDA +15%, but QoQ PAT declined -12.2%
Robust order book of ₹185 Cr in composites
METOrder book cited; coupled with ₹400 Cr packaging orders for FY27
Value-added products driving higher margins
MISSValue-added product share only 25.4% vs prior target of 35% in 2 years
Working capital managed well
MISSCycle time 110 days in Q1 vs target 90 days; deteriorated from 100 days in Dec 2025
Earnings quality
What changed since the last call
Value-added product share
DowngradeTarget 35% of sales in 2 years; currently only 25.4%. Composite order book ₹185 Cr supports growth but mix not yet achieved
Working capital cycle
DowngradeDeteriorated to 110 days from 100 days in Dec 2025 due to polymer price spike; target remains 90 days
ROCE trajectory
NeutralMaintained +1.75% annual increase plan; March 2026 was 19%, targeting 24% in 3 years (by March 2029)
Solar power cost savings
UpgradeAchieved ₹12 Cr this year; targeting ₹35 Cr if all operating states adopt green power policy
Guidance for volume/margin growth
NeutralReaffirmed >15% volume growth, 25-30% composite growth, 19-20% EBITDA growth, 23-24% PAT growth; no change
The Q&A
Analysts pressed hard on working capital deterioration, polymer price pass-through lag, PE pipe volume softness, and debt/finance cost reconciliation. Management was candid on timing issues in PE pipes and inflation hedging via monthly pricing, but deflected detailed debt reconciliation to CFO follow-up. Overall moderate pressure, no sharp skepticism; analysts seemed satisfied on composites trajectory.
Working capital & cash deployment — Kumar Saurabh, Scientific Investing
PartialWorking capital cycle at 110 days due to March polymer spike; target 90 days by year-end. On cash deployment: following board/investor guidelines; open to organic/inorganic growth if ROCE >target. Buyback and dividend payout ratio increase also under consideration from FY27 onwards.
Polymer pricing & pass-through — Karan, Guardian Capital Partners
Answered75% customers on monthly pricing (8-12th of each month). Major increases March-April fully passed on; July decreases (₹23 Cr) passed with 1-month lag. With 3-month lag, no net pricing gap. 25% other products (composites) with 6-month inventory carry fixed pricing.
PE pipe weakness & crude assumptions — Aryan, Equitas Investments
AnsweredQ1 soft due to government not passing EPC contractor cost increases; Q2-Q3 recovery expected. Reasonable crude $70-80/bbl (oil producer needs $55 profit); implies polymer $1,100-1,250. At normalized levels, EBITDA margin 14-15.5% is sustainable.
LPG cylinder domestic/export split — Rohit Suresh, Samatva Investments
AnsweredNormally 50-50 domestic/export. Within domestic: entirely PSU (HPCL, IOCL, BPCL). Non-PSU only legacy (Reliance repurposing old stock); not current supply.
Debt, finance cost, other income reconciliation — Devam, ARDEKO Asset Management
PartialCost of funds 8.5% India / 6.5% overseas. QIP proceeds in FD; interest netted off, not in other income. Other income ₹1 Cr (rental income only). Finance cost ₹35-40 Cr on non-fund-based facilities (bank guarantees, LC, documentation); not debt interest.
Guidance
FY27 volume growth >15% (maintained from prior calls)
HighComposite 25-30%, PE pipe 20-25%, packaging 11-13%, others 10-12%. Combined 15%+ growth
EBITDA growth 19-20%, PAT growth 23-24% when 15% volume achieved (FY27)
HighAssumes normalized polymer prices. Driven by automation, power cost savings (₹12-35 Cr), manpower reduction, finance cost decline
EBITDA margin target 14-15.5% at normalized polymer prices ($70-80 oil, $1,100-1,250 polymer)
MediumQ1 delivered 13.3%; depends on commodity stabilization and monthly pricing pass-through effectiveness
FY26-27 capex ₹350 Cr (consolidation phase); post-2027 normalized to ₹200-250 Cr annually
HighIncludes ₹28 Cr maintenance, ₹47 Cr value-added this Q. Automation, new capacity (Gujarat, Odisha, Chiplun, Saudi), recycling expansion
Risks the call surfaced
Commodity volatility
HighPolymer prices $600-1,800 range historically. 20-25 day pass-through lag creates margin compression risk if prices spike suddenly
Government project dependency
MediumQ1 PE pipe volumes weak due to government not passing cost increases to EPC contractors. H2 dependent on rains ending and project resumption
Working capital deterioration
MediumCycle time 110 days vs 90-day target; deteriorated from 100 days in Dec 2025 due to raw material price spikes and inventory carry
Value-added product mix lag
MediumValue-added products (composite, IBC) only 25.4% of sales; two-year target 35%. Margin expansion strategy partially behind
Geopolitical disruption
MediumOngoing geopolitical tensions affect raw material pricing, shipping costs, export demand (Ebullient 60% export to Middle East). Macro uncertainty caps guidance from price perspective
Management
Score 7/10. Detailed, technical but verbose. MD provided granular insights on pricing mechanisms, working capital calculations, polymer fundamentals. Defensive on some metrics (working capital, finance costs) but ultimately transparent. Invited deeper discussion rather than dodge. Mixed. Hit composite 25-30% guidance (29.3% delivered), volume growth on track (11% Q1 toward 15% FY27). Missed working capital targets (110 days vs 90-day goal). Value-added mix lagging (25.4% vs 35% target). Debt reduction on track (₹90 Cr this Q). PAT growth 22% vs guidance of 23-24% when 15% volume achieved—slightly short.
1 · Aug-Sep 2026
PE pipe recovery; 75% capacity utilization targeted (post-rains, Q2 focus)
2 · H2 FY27
Fire extinguisher commercial production; 800k units targeted for refinery/oil companies
3 · Sep-Oct 2026
LPG composite cylinder approvals (250-350L CNG cascade); reduce cost vs competition
Suitable as a quality compounder with execution risk.
Composite Momentum Dims as QoQ Softness and Working Capital Lags Signal Execution Risk
Headline numbers gleam—25% revenue growth, 22% PAT growth, composites beating guidance at 29%—but the quarter reveals deeper strain. QoQ profit fell 12%, working capital deteriorated to 110 days (vs. 90-day target), value-added product mix stuck at 25.4% (vs. 35% goal). Management reiterated guidance rather than raising it, signalling caution on polymer volatility and macro headwinds. The market agrees: stock down 15.6% from its high, FII trimming positions.
+25.1%
₹1,694 Cr | Strong pricing power
+22.2%
₹116 Cr | Offset by −12.2% QoQ slide
+11% YoY
Q1 pace toward 15% FY27 target
29.3%
Beats 25–30% guidance; ₹185 Cr order book
The quarter opens strong on the headline—25% revenue, 22% profit growth, composites delivering the promised 29%—yet management's refusal to raise guidance tells the real story. The disconnect lies not in the numbers themselves but in what sits beneath: a 12% quarter-on-quarter PAT decline buried by seasonality (Q1 is only 22% of full-year sales), a working capital cycle stuck at 110 days when management's own target is 90, and a strategic shift toward higher-margin value-added products that remains 10 percentage points short of the two-year ambition. This is a company executing well on one vector (composites) while struggling on execution (working capital, margin mix) on others.
What the numbers reveal
Q1 profit of ₹116 Cr (+22% YoY) is clean—no one-time gains to strip out—but the organic read requires context. EBITDA grew 15% YoY to ₹225 Cr, a modest climb vs. the 25% revenue lift, indicating that gross margin compression from polymer cost inflation (75% of COGS) is real, even with 75% of customers on indexed monthly pricing. Volume growth of 11% YoY shows pricing power, but the 25% pricing component means the business is running at nearly double the volume growth rate—pricing, not volume, is driving the narrative.
The quarter-on-quarter 12.2% PAT decline is neither a red flag nor accidental: it reflects genuine seasonal trough (Q1 = 22% of annual sales) and raw material inventory carry for composite government contracts. But it signals risk if macro deteriorates. Operating cash flow of ₹155 Cr in Q1 is healthy; capex of ₹75 Cr (₹28 Cr maintenance, ₹47 Cr value-added) shows continued investment in automation and new composite capacity.
Composite products delivering 25–30% growth
SupportedComposite growth 29.3% YoY; order book ₹185 Cr
PAT growth 22% reflects operational excellence
OverstatedPAT +22% YoY but −12% QoQ; EBITDA +15% vs. volume +11% shows pricing, not margin expansion
Value-added products (composite, IBC) driving margin uplift
ContradictedValue-added share only 25.4% vs. prior two-year target of 35%
Working capital managed effectively
ContradictedCycle time 110 days vs. 90-day target; deteriorated from 100 days in Dec 2025 due to polymer price spike
Strong order book visibility for revenue
SupportedComposite ₹185 Cr + packaging ₹400 Cr confirmed orders provide path to 15%+ FY27 volume growth
What changed on this call
Guidance maintained, not raised. Management reaffirmed >15% volume growth for FY27, 25–30% composite growth, 20–25% PE pipe growth, 11–13% packaging growth. This is the same guidance from the prior call—despite hitting composite targets early and delivering solid Q1 headline numbers. The message: macro headwinds (polymer volatility $600–1,800/ton range historically; reasonable normalized $1,100–1,250/ton) and government capex cycle uncertainty (PE pipes, 35–40% of H1 revenue, were soft Q1 due to EPC contractor cost-pass delays) warrant caution.
Working capital target missed, recovery dependent on stabilization. Management blamed the March polymer price spike and inventory carry for composite government projects; acknowledged the 110-day cycle vs. 90-day target but committed to reaching 100 days by year-end. This is a capital-tied risk if raw material inflation resurfaces.
Value-added product mix lagging strategic plan. At 25.4% of sales, the mix is still 10pp short of the two-year target of 35%. Composite order book momentum (₹185 Cr, 29.3% growth) suggests the ramp is underway, but timeline extensions signal execution is harder than prior calls implied.
Solar power savings upgraded. ₹12 Cr of solar cost savings realized in Q1; management targeting ₹35 Cr potential if all operating states adopt green power policy. This is a real structural cost advantage if the rollout materializes.
How the street is reading it
The stock traded ₹207.26 on the day before results and moved −0.21% on day 1 post-announcement—a fade that has only modestly recovered (day 3 +0.12%, day 5 +0.63%). This muted reaction is telling: the market had already priced caution into the name. Today at ₹185.67, the stock is down 15.6% from its all-time high of ₹220 and is now trading below all three major moving averages (SMA20 ₹204.42, SMA50 ₹190.97, SMA200 ₹186.68). The RSI of 13.1 signals severe oversold conditions, typical of a stock that has sold off sharply on sentiment or sector rotation rather than a fundamental collapse.
Institutional ownership tells the story. FII stakes have declined from 10.88% in Q4 FY26 to 8.53% in Q1 FY27—a 235 basis point trimming, suggesting offshore money is unconvinced by the execution narrative. DII holdings rose modestly (17.37% → 17.57%), implying domestic institutional investors are holding or nibbling, but the FII exit is the louder signal. Promoter stakes are stable at 47.56%.
This price action—the post-result fade, the institutional trimming, the overshoot to oversold RSI—confirms the fundamental read: the market wants to see working capital recovery and value-added product mix expansion prove out before re-rating the stock higher. The headline growth story is credible; the execution story is not yet assured.
Composite order book ₹185 Cr, 29.3% Q1 growth beats 25–30% guidance; demonstrates pricing power and market share gains
Packaging order book ₹400 Cr (FY27) confirms revenue visibility for largest segment (75% of sales, 11–13% growth guidance)
Automation capex (₹350 Cr over FY26–27) and solar cost savings (₹12–35 Cr realized/targeted) provide structural cost advantage
Pricing power proven: 11% volume growth YoY with 25% pricing component shows B2B moat vs. commodity exposure
Debt reduced ₹90 Cr this quarter; targeting debt-free balance sheet within 12–18 months; improves financial flexibility
QoQ PAT decline −12.2% signals momentum loss; Q1 is only 22% of FY sales but raises H2 risk if macro deteriorates
Working capital cycle 110 days vs. 90-day target; deteriorated from 100 days in Dec 2025; capital tie-up risk if inflation resurfaces
Value-added product mix 25.4% vs. 35% two-year target; margin expansion delayed by 12–18 months on current trajectory
Guidance maintained (not raised) despite hitting composite targets; signals management caution on polymer volatility and government capex cycles
PE pipe segment (35–40% of H1 revenue) soft Q1 due to EPC contractor cost-pass delays; recovery Q2–Q3 dependent on rains and project resumption
Finance costs ₹35–40 Cr (non-fund-based facilities: bank guarantees, LC) remain despite debt reduction; limits path to true debt-free status
FII institutions trimmed 235bp (10.88% → 8.53%) this quarter; signals offshore skepticism on execution narrative
Polymer price volatility ($600–1,800/ton range historically; 75% of COGS)
HighQ1 spike to ₹1,800/ton (March) caused working capital deterioration and inventory carry. Monthly pass-through lag (20–25 days) creates margin compression risk if prices spike again. EBITDA target of 14–15.5% at normalized $70–80 oil ($1,100–1,250 polymer) is dependent on commodity stability.
Working capital cycle lagging (110 days vs. 90-day target; deteriorated from 100 days Dec 2025)
HighCapital tie-up increases ROIC drag and limits dividend/buyback capacity. If raw material costs resurface or receivables lengthen, this could become a cash-flow constraint. Management targeting 100 days by year-end—credible but not yet proven.
Value-added product mix expansion stalled (25.4% vs. 35% two-year target; 10pp shortfall)
MediumMargin expansion strategy is the bull case, but execution is lagging. Composite order book ₹185 Cr and 29.3% growth suggest momentum is building, but timeline extension to 3+ years caps near-term re-rating. Delays also suggest market adoption or capacity constraints.
Government capex cycle dependency (PE pipes 35–40% of H1 revenue; soft Q1 due to EPC cost-pass delays)
MediumInfrastructure capex is lumpy and dependent on government project execution. Q1 weakness due to EPC contractors not passing cost increases suggests project economics are tight. H2 recovery dependent on rains ending and project resumption—not fully in management's control.
Geopolitical uncertainty (Russia-Ukraine, West Asia conflicts) affecting raw material costs and shipping
MediumOngoing tensions create volatility in energy prices, raw material sourcing, and shipping costs. Ebullient Packaging acquisition (pending) has 60% Middle East export exposure—geopolitical risk to deal closure and profitability.
FII institutional trimming (235bp reduction this quarter to 8.53%)
MediumOffshore money exit suggests skepticism on execution and valuation. If FII outflow accelerates, liquidity and stock momentum could deteriorate further. Current oversold RSI (13.1) could spike back if FII selling resumes.
1 · Q2 working capital cycle (Aug–Sep 2026 results, Oct–Nov guidance)
Management targets 100 days by year-end; Q2 is the acid test. If the cycle remains at 110+ days or deteriorates further, it signals either persistent commodity inflation or operational slippage. Conversely, recovery to 100 days by Q3 validates the interim pressure as temporary.
2 · PE pipe recovery and capacity utilization (Aug–Sep 2026)
Management expects 75% capacity utilization targeted post-rains (Q2 focus). Q1 was soft due to EPC contractor delays; Q2–Q3 recovery is a key catalyst if project resumption accelerates. If Q2 PE pipe volumes remain weak, it signals government capex cycle headwinds persist.
3 · Value-added product mix progress (H2 FY27, Jan 2027 results)
Fire extinguisher commercial production targeting 800k units for refinery/oil companies (H2), LPG composite cylinder approvals (Sep–Oct), hydrogen cylinder Type 3/4 approvals. These are Q4 catalysts; if realized, mix could tick higher. If delayed, margin expansion timeline extends further.
4 · Composite order book conversion to revenue (H2 FY27)
₹185 Cr composite order book must convert to actual Q2–Q3–Q4 revenue for 29% growth sustainability. If orders slip or convert at lower margins (due to pricing pressure), it signals competitive intensity and margin risk.
5 · Dhule PE pipe facility and Ebullient acquisition progress (Q2 FY27 update)
Dhule facility (₹25 Cr equity acquisition) targeting commercial production Q2; Ebullient (pending, conditional on war stabilization). These are growth levers; delays or deal termination would signal capex disappointment or macro risk re-assessment.
Time Technoplast delivered a headline quarter—25% revenue growth, 22% PAT growth, composite products beating guidance—but the quarter is defined by what sits beneath: a QoQ profit decline, working capital lagging, and margin expansion delayed. The management refusal to raise guidance, despite hitting composite targets, is the honest tell: macro headwinds (polymer volatility, government capex cycles) and execution risks (working capital, product mix expansion) are real constraints, not narrative noise.
The market's 15% sell-off from ATH and FII trimming reflect this sober reading. The stock is oversold on RSI, but oversold does not mean cheap—it means the market is waiting for proof. The next proof points are Q2 working capital recovery (100 days target by year-end), PE pipe capacity recovery (75% utilization post-rains), and value-added product mix traction (fire extinguisher, LPG cylinder approvals H2). Until then, this is a quality compounder with execution risk—a hold.
The number to track from here: working capital cycle days. If Q2 lands at 100–105 days, the execution narrative stabilizes and a re-rate becomes likely. If it remains at 110+ days, capital concerns persist and the stock could test lower. This is the metric that separates the bull from the bear.
Time Technoplast Q1FY27: consol PAT +22% YoY to ₹118 Cr as margin guidance missed
PAT +22.07% YoY · revenue +25.14% · margins compressing
₹1,692.71 Cr
+25.14% YoY
₹117.86 Cr
+22.07% YoY
6.96%
-0.2pp YoY
₹2.35
Time Technoplast's consolidated revenue rose 25.1% YoY to ₹1,692.71 Cr (from ₹1,352.65 Cr) and was roughly flat QoQ (+0.96% from ₹1,676.67 Cr). Consolidated PAT was ₹117.86 Cr, up 22.1% YoY (from ₹96.55 Cr) but down 12.2% QoQ (from ₹134.31 Cr) — profit growth trailed revenue growth, and with no exceptional items in either comparison period this is a clean, not one-off-distorted, read.
Q1 FY-2027 vs prior quarters
The gap is a margin story. Operating EBITDA margin fell to 13.31% from 14.47% a year ago and 14.62% last quarter; net profit margin fell to 6.96% from 7.13% YoY and 7.99% QoQ. Both segments show the same pattern: Polymer Products revenue grew 24.6% YoY to ₹1,072.74 Cr while segment PBIT grew only 15.9% to ₹102.05 Cr, and Composite Products revenue grew 26.2% YoY to ₹619.97 Cr while segment PBIT grew 14.7% to ₹71.31 Cr — so this isn't one weak segment dragging the mix, both ran hot on revenue and cooler on profit. That directly contradicts the margin-expansion plank of management's Feb-2026 (Q3 FY26) guidance, which had targeted 25-30% growth in high-margin composite products, a rising value-added mix (35% of sales within two years) and automation/solar savings to lift margins — instead OPM printed at its lowest of the four quarters shown in this filing. The one guidance line the company is delivering on is deleveraging: finance costs fell 22.6% YoY to ₹16.88 Cr as debt/equity improved to 0.13 (from 0.20 a year ago and 0.16 last quarter), helped by the ₹800 Cr QIP completed in November 2025, ₹400 Cr of which was used to prepay borrowings; the company also fully repaid its outstanding commercial paper on July 23, 2026. Even so, the balance sheet is not yet debt-free — the six-month debt-free target flagged on the Feb-2026 call has not been met, though leverage has fallen materially and ₹342.98 Cr of QIP proceeds remain unutilised as of June 30, 2026 for further deleveraging or inorganic growth.
The stock went into the print at ₹207.26, up 17.7% over the past month of trading.
For context: revenue is at a 6-quarter high.
Management projects consolidated revenue growth exceeding 15% annually for the next three years, driven by 25-30% growth in high-margin composite products. The company guides for significant margin expansion through an increasing mix of value-added products (targeting 35% of sales in two years), substantial cost saving
— This quarter: missed
A web search for Q1 FY27-specific street estimates for this company returned nothing concrete, so vsStreet is not assessed here; management gives no formal guidance figure beyond the Feb-2026 qualitative targets referenced above, and no separate management press release accompanied this filing. On guidance, the quarter beats on revenue growth (+25% YoY vs the >15% annual target) but misses on margins (compression instead of expansion) and is still short of the debt-free promise. Standalone results ran hotter than consolidated — revenue +34.9% YoY to ₹866.83 Cr and PAT +25.3% YoY to ₹56.17 Cr — a few points ahead of the consolidated growth rates, consistent with the parent outgrowing some subsidiaries this quarter. Alongside the results, the board appointed two additional independent directors (Devendra Jitendra Shah and Hema Rajendra Gaitonde) and reconstituted board committees; neither has a P&L impact.
W1
Whether OPM reverses off this quarter's 13.31% print as the guided value-added-product mix (targeted 35% of sales in two years) and automation/solar savings come through
W2
Progress toward the debt-free balance sheet target guided for within six months of the Feb-2026 call — D/E was still 0.13 this quarter with ₹342.98 Cr of QIP proceeds unutilised
W3
FY27 ROCE trajectory toward the 20% target flagged in Feb 2026 — not disclosed in this filing
No exceptional items either period (raw = adjusted growth). Standalone other income is nil in both the current and year-ago quarter columns. Our DB's year-ago EPS (₹4.19) doesn't match the filing's restated ₹2.10 for 30.06.2025 — likely a weighted-average-share methodology difference post the Nov-2025 QIP; not used in any output field.